Frazier Life Sciences Management, L.p.

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 47
Total Value: 2187908599
Accession Number: 0001892134-25-000005
Form Type: 13F-HR
CIK: 0001892134
Manager Name: Frazier Life Sciences Management, L.p.

Data Enrichment

96% identified

45 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

47 positions • $2,187,908.599K total value

47 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 1 of 3

Sort by:

NewAmsterdam Pharma Co N.V.

NAMS|N62509109

16116418(+1.3%)

Value:

$329.9B(-19.3%)

Mirum Pharmaceuticals, Inc.

MIRM|604749101

6795121(+3.4%)

Value:

$306.1B(+12.7%)

Verona Pharma plc

VRNA|925050106

3457850(+2.2%)

Value:

$219.5B(+39.7%)

Arcutis Biotherapeutics, Inc.

ARQT|03969K108

8785284(+0.0%)

Value:

$137.4B(+12.3%)

BridgeBio Pharma, Inc.

BBIO|10806X102

3800457(+0.0%)

Value:

$131.4B(+26.0%)

Krystal Biotech, Inc.

KRYS|501147102

688460(-12.7%)

Value:

$124.1B(+0.5%)

Disc Medicine, Inc.

IRON|254604101

1754834(+0.0%)

Value:

$87.1B(-21.7%)

Tarsus Pharmaceuticals, Inc.

TARS|87650L103

1397527(-12.0%)

Value:

$71.8B(-18.3%)

Trevi Therapeutics, Inc.

TRVI|89532M101

10259409(-3.8%)

Value:

$64.5B(+46.9%)

Phathom Pharmaceuticals, Inc.

PHAT|71722W107

10109279(+0.0%)

Value:

$63.4B(-22.8%)

KalVista Pharmaceuticals, Inc.

KALV|483497103

4887867(+0.0%)

Value:

$56.4B(+36.2%)

578784100

4129001

Value:

$45.5B

MBX Biosciences, Inc.

MBX|55287L101

5985347(+0.0%)

Value:

$44.2B(-60.0%)

RHYTHM PHARMACEUTICALS, INC.

RYTM|76243J105

678760(-63.7%)

Value:

$36.0B(-65.7%)

SOLENO THERAPEUTICS INC

SLNO|834203309

499159(-28.6%)

Value:

$35.7B(+13.5%)

Revolution Medicines, Inc.

RVMD|76155X100

997455(+0.0%)

Value:

$35.3B(-19.1%)

Savara Inc

SVRA|805111101

11462301(+32.4%)

Value:

$31.8B(+19.4%)

AGIOS PHARMACEUTICALS, INC.

AGIO|00847X104

1069854(+0.0%)

Value:

$31.3B(-10.8%)

Erasca, Inc.

ERAS|29479A108

22575851(+16.4%)

Value:

$30.9B(-36.5%)

Ultragenyx Pharmaceutical Inc.

RARE|90400D108

658715(+0.0%)

Value:

$23.9B(-13.9%)

Instrument	Shares		Other Manager	Value
Newamsterdam Pharma Co N.V.(NAMScusipN62509109)	16.1M	QoQ +1.25% (-200.0K) YoY +31.81% (+3.9M)	All Managers (Combined)	$329.9M	QoQ -19.34% (-$79.1M) YoY +14.08% (+$40.7M)
Mirum Pharmaceuticals, Inc.(MIRMcusip604749101)	6.8M	QoQ +3.42% (+224.7K) YoY +4.61% (+299.7K)	All Managers (Combined)	$306.1M	QoQ +12.67% (+$34.4M) YoY +87.61% (+$143.0M)
Verona Pharma Plc(VRNAcusip925050106)	3.5M	QoQ +2.18% (+73.9K) YoY +14.71% (+443.5K)	All Managers (Combined)	$219.5M	QoQ +39.69% (+$62.4M) YoY +352.64% (+$171.0M)
Arcutis Biotherapeutics, Inc.(ARQTcusip03969K108)	8.8M	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$137.4M	QoQ +12.27% (+$15.0M) YoY +57.82% (+$50.3M)
Bridgebio Pharma, Inc.(BBIOcusip10806X102)	3.8M	QoQ 0.00% (+0) YoY +11.26% (+384.9K)	All Managers (Combined)	$131.4M	QoQ +25.98% (+$27.1M) YoY +24.40% (+$25.8M)
Krystal Biotech, Inc.(KRYScusip501147102)	688.5K	QoQ -12.68% (-100.0K) YoY -30.35% (-300.0K)	All Managers (Combined)	$124.1M	QoQ +0.49% (-$609.2K) YoY -29.42% (-$51.7M)
Disc Medicine, Inc.(IRONcusip254604101)	1.8M	QoQ 0.00% (-0) YoY +123.54% (+969.8K)	All Managers (Combined)	$87.1M	QoQ -21.70% (-$24.1M) YoY +78.23% (+$38.2M)
Tarsus Pharmaceuticals, Inc.(TARScusip87650L103)	1.4M	QoQ -11.96% (-190.0K) YoY -21.81% (-390.0K)	All Managers (Combined)	$71.8M	QoQ -18.32% (-$16.1M) YoY +10.48% (-$6.8M)
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	10.3M	QoQ -3.80% (-405.4K) YoY +38.99% (+2.9M)	All Managers (Combined)	$64.5M	QoQ +46.86% (-$20.6M) YoY +153.41% (+$39.1M)
Phathom Pharmaceuticals, Inc.(PHATcusip71722W107)	10.1M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$63.4M	QoQ -22.78% (-$18.7M) YoY -40.96% (-$44.0M)
Kalvista Pharmaceuticals, Inc.(KALVcusip483497103)	4.9M	QoQ 0.00% (+0) YoY +32.53% (+1.2M)	All Managers (Combined)	$56.4M	QoQ +36.24% (+$15.0M) YoY +28.96% (+$12.7M)
(cusip578784100)✕	4.1M	QoQ NEW(+4.1M) YoY NEW(+4.1M)	All Managers (Combined)	$45.5M	QoQ NEW(+$45.5M) YoY NEW(+$45.5M)
Mbx Biosciences, Inc.(MBXcusip55287L101)	6.0M	QoQ 0.00% (-0) YoY NEW(+6.0M)	All Managers (Combined)	$44.2M	QoQ -59.95% (-$66.1M) YoY NEW(+$44.2M)
Rhythm Pharmaceuticals, Inc.(RYTMcusip76243J105)	678.8K	QoQ -63.69% (-1.2M) YoY -69.00% (-1.5M)	All Managers (Combined)	$36.0M	QoQ -65.65% (-$68.7M) YoY -62.11% (-$58.9M)
Soleno Therapeutics Inc(SLNOcusip834203309)	499.2K	QoQ -28.60% (-200.0K) YoY -42.99% (-376.5K)	All Managers (Combined)	$35.7M	QoQ +13.48% (-$4.2M) YoY -4.83% (-$1.8M)
Revolution Medicines, Inc.(RVMDcusip76155X100)	997.5K	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$35.3M	QoQ -19.15% (-$8.4M) YoY +9.71% (+$3.1M)
Savara Inc(SVRAcusip805111101)	11.5M	QoQ +32.35% (+2.8M) YoY +186.55% (+7.5M)	All Managers (Combined)	$31.8M	QoQ +19.41% (+$5.2M) YoY +59.39% (+$11.8M)
Agios Pharmaceuticals, Inc.(AGIOcusip00847X104)	1.1M	QoQ 0.00% (-100) YoY +104.49% (+546.7K)	All Managers (Combined)	$31.3M	QoQ -10.82% (-$3.8M) YoY +104.91% (+$16.0M)
Erasca, Inc.(ERAScusip29479A108)	22.6M	QoQ +16.42% (-3.2M) YoY NEW(+22.6M)	All Managers (Combined)	$30.9M	QoQ -36.45% (-$17.7M) YoY NEW(+$30.9M)
Ultragenyx Pharmaceutical Inc.(RAREcusip90400D108)	658.7K	QoQ 0.00% (-0) YoY NEW(+658.7K)	All Managers (Combined)	$23.9M	QoQ -13.92% (-$3.9M) YoY NEW(+$23.9M)